Response to Boctor and Smith

American Journal of Hematology

Volumn 83, Issue 3, 2008, Pages 256-

  Whitlatch, Nicole L ^a   Martin, Michael G ^b   Shah, Bijal D ^a   Arepally, Gowthami M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS 13 PROTEASE ANTIBODY; ENZYME ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG USE; ENZYME ACTIVITY; HUMAN; LETTER; MICROANGIOPATHY; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SYMPTOM; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 39749112526     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21079     Document Type: Letter

References (4)